hepatic edema
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age 20 years old or older 2)The patient that an own strength walk is possible 3)The patient who can list in an interview vote by oneself 4)the patient that agree the participation to this 5)The patient who meets the following clinical inspection standards a) A hemoglobin level: >= 8.0 g/dl b) A neutrophilic number: >= 1,000/mm3 c) The number of the platelets: >= 30,000/mm3 e) ALT and AST level: 6 times of the <= facilities standard
Exclusion criteria
Exclusion criteria: 1) The patient who has an applicable heart trouble as follows a) Congestive heart failures more than NYHA class 3 b) The high blood pressure that it is poor in control 2) Dangerously ill patient (except HBV, the HCV) who and has an infectious disease of the activity 3) Patient with a history of the HIV infection 4) Patient during hemodialysis 6) Patient of hepatic encephalopathy having difficulty in appropriate hydration 7) The patient who was treated whom patient 8) who produced the gastrointestinal tract bleeding that a blood transfusion and measures need within four weeks before this study start corresponds below to a) Whole body chemotherapy within four weeks before this study start b) The patient who has difficulty in 9 operation) drug remedy under the general anesthesia within four weeks before this study start 10) When may spoil the security of the patient in 13 patient) others affecting the evaluation of this study entry and result, this study enforcement or when the observance of this study enforcement plan is judged with difficulty by 12 patient) drug abuse that may wake up an allergic reaction for possibility of during a pregnant woman, the nursing and the pregnancy or this patient 11) study drug with the intention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the survival days of the cirrhotic patientunder tolvaptan | — |
Countries
Japan
Contacts
NIPPON MEDICAL SCHOOL HOSPITAL gastroenterology